Agree, even thought ADAPT has been clinically proven to provide the most durable valve technology on the market there wasn't a point of difference with the other product which had less durability, TAVR now being prefer method of heart surgery for younger patient is the game changer so valve durability is a very important point of difference when comparing other product on the market.
Agree, even thought ADAPT has been clinically proven to provide...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.61 |
Change
-0.560(2.78%) |
Mkt cap ! $376.9M | |||
| Open | High | Low | Value | Volume |
| $20.18 | $20.20 | $19.60 | $178.1K | 8.889K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61 | $19.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 1500 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.60 |
Change
-0.560 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| $20.04 | $20.04 | $19.60 | 223 | ||
| Last updated 15.49pm 17/05/2024 ? | |||||
| AVR (ASX) Chart |